About
Sequana Medical NV is a Belgium-based medical device company that specializes in innovative treatment solutions for fluid overload conditions related to liver disease, heart failure, and cancer. The company primarily targets patients experiencing diuretic-resistant fluid overload, which can lead to severe symptoms and increased healthcare needs. The core technology of Sequana Medical includes the alfa pump® system, a fully implantable device that helps move excess fluid from the abdomen to the bladder for natural elimination. This system is designed to enhance patients' quality of life and reduce healthcare costs. Additionally, the company is developing DSR® therapy, which is currently undergoing pre-clinical and clinical investigations. Headquartered in Ghent, Belgium, Sequana Medical is publicly traded on Euronext Brussels under the ticker SEQUA.BR. The company is committed to improving patient outcomes and healthcare efficiency through its advanced medical devices and therapies.
Technologies
Keywords
Company Information
-
Employees 44
-
Founded 2006
-
Annual Revenue $785000
-
Total Funding $128235552
Location
1112 Kortrijksesteenweg, Ghent, Flanders, Belgium, 9051